Oral preparation containing ranolazine hydrochloride for treating cardiovascular disease

A technology of ranolazine hydrochloride and oral preparations, which is applied in the field of oral preparations containing ranolazine hydrochloride for the treatment of cardiovascular diseases, and can solve the problems of incomplete absorption, incomplete absorption by the human body, incomplete release, etc., and achieve complete absorption and utilization and reduced dosage , the effect of reducing individual differences

Inactive Publication Date: 2006-04-05
HUAZHONG NORMAL UNIV
View PDF4 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The API of the patent formulation is ranolazine free base, and the patent fails to provide definite data to prove that the pH-dependent adhesive promotes the release of ranolazine free base in the intestinal tract, and the AUC of its formulation 0～24 Significantly smaller than immediate-release preparations, suggesting that incomplete release may lead to incomplete absorption by the human body
Since the acrylic resin and ranolazine free base are intimately mixed, the former being swellable in intestinal fluids, and ranolazine free base being slightly soluble to almost insoluble in intestinal fluids, the adhesive prevents the complete release of ranolazine free base resulting in absorption in the body incomplete

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Composition and preparation method of 200mg ranolazine hydrochloride compressed tablet

[0037] Mix 200.0 g of ranolazine hydrochloride, 100.0 g of microcrystalline cellulose, 40.0 g of calcium hydrogen phosphate, and 40.0 g of micropowdered silica gel, use 40 wt% ethanol aqueous solution as a wetting agent to make a soft material, granulate with a 20-mesh sieve, and ventilate and dry at 60°C After 4 hours, granulate, add 5.0 g of sodium carboxymethylcellulose and 5.0 g of magnesium stearate, mix well and press to obtain about 1000 round tablets, each containing 200 mg of ranolazine hydrochloride, to obtain compressed tablets.

Embodiment 2

[0039] Composition and preparation method of 300mg ranolazine hydrochloride compressed tablet

[0040] Mix 300.0g of ranolazine hydrochloride, 100.0g of microcrystalline cellulose, 30.0g of calcium hydrogen phosphate, and 30.0g of micropowdered silica gel, and use 60wt% ethanol aqueous solution containing 5wt% polyvinylpyrrolidone as a wetting agent to make a soft material through a 20-mesh sieve Granulate, ventilate and dry at 60°C for 3 hours, granulate, add 15.0 g of micropowder silica gel and 5.0 g of magnesium stearate, mix evenly, and press to obtain about 1000 capsule-shaped tablets, each containing 300 mg of ranolazine hydrochloride, to obtain compressed tablets.

Embodiment 3

[0042] Composition and preparation method of 500mg ranolazine hydrochloride compressed tablet

[0043] Mix 500.0 g of ranolazine hydrochloride, 60.0 g of microcrystalline cellulose, 50.0 g of calcium hydrogen phosphate, and 40.0 g of micropowdered silica gel, make a soft material with 70 wt % ethanol aqueous solution as a wetting agent, granulate with a 20-mesh sieve, and ventilate and dry at 60 ° C After 3 hours, granulate, add 10.0 g of micropowder silica gel, 15.0 g of polyvinylpyrrolidone, and 5.0 g of magnesium stearate, mix well, and press to obtain capsule-shaped tablets, each containing 500 mg of ranolazine hydrochloride, to obtain compressed tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An orally-applied ranolazine hydrochloride for treating cardiovascular disease is prepared from ranolazine hydrochloride, diluent, adhesive, disintegrant, antisticking agent and lubricant through adding wetting agent, preparing soft material, granulating and drying.

Description

Technical field: [0001] The invention relates to an oral preparation containing ranolazine hydrochloride for treating cardiovascular diseases and a preparation method. Administration of this preparation maintains ranolazine in human plasma at a therapeutic level. Background technique: [0002] Ranolazine is (±)-N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)-propyl]-1-piperazine Amide was first disclosed by U.S. Patent No. 4,567,264, which explained that ranolazine and its pharmaceutically acceptable salts had superior medical functions, and disclosed that it was used for the treatment of cardiac arrhythmias, variability and exercise angina, and myocardial infarction. Vascular disease. [0003] U.S. Patent No. 5,506,229 discloses the use of ranolazine and its pharmaceutically acceptable salts for treating physically and chemically damaged tissues, including cardioplegia, hypoxia or reperfusion injury of heart and skeletal muscle or brain tissue, and also discloses...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/495A61P9/06A61P9/10A61K9/00
Inventor 杨光富刘祖明卿湘华
Owner HUAZHONG NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap